August 22, 2019
Rose
Stories of the fatal decision to skip or ration insulin have filled headlines in recent months, but new government data shows just how many people are taking those dangerous measures because of high costs. In other pharmaceutical news: Gilead's stand-off with the government over Truvada, tips for shopping abroad for cheaper meds, and more.
from Kaiser Health News https://ift.tt/30rZ1MY
August 22, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
New Laws Let Visitors See Loved Ones in Health Care Facilities, Even in an Outbreak- A Shortfall of ECMO Treatment Cost Lives During the Delta Surge
- California Handed Its Medicaid Drug Program to One Company. Then Came a Corporate Takeover.
- The Pandemic Exacerbates the ‘Paramedic Paradox’ in Rural America
- Journalists Discuss Insulin Costs and Ethical Questions Surrounding a North Carolina Rehab Program
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment